Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Puma Biotechnology, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 78 | 68 | −10 |
| Shares | 27.8M | 26.6M | −1.22M (−4.4%) |
| Value | $86.1M | $93.8M | +$7.74M (+9.0%) |
New holders (3)
Institutions that held Puma Biotechnology, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 114,698 | $405.0K | 0.04% |
| Rhumbline Advisers | 2,086 | $7.36K | 0.00% |
| Impact Partnership Wealth, LLC | 308 | $1.09K | 0.00% |
Sold out (13)
Institutions that held Puma Biotechnology, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Qube Research & Technologies Ltd | 76,685 | $237.0K |
| Man Group plc | – | $193.0K |
| 683 Capital Management, LLC | 36,500 | $112.8K |
| Boothbay Fund Management, LLC | 24,229 | $74.9K |
| Walleye Capital LLC | 19,837 | $61.3K |
| Jane Street Group, LLC | 17,697 | $54.7K |
| Bailard, Inc. | 14,102 | $43.6K |
| Wolverine Trading, LLC | 12,944 | $37.0K |
| Lighthouse Investment Partners, LLC | 11,276 | $34.8K |
| Point72 Asset Management, L.P. | 11,000 | $34.0K |
| Group One Trading, L.P. | 3,733 | $11.5K |
| Quantbot Technologies LP | 3,600 | $11.1K |
| The PNC Financial Services Group, Inc. | 123 | $380 |